1. Home
  2. CRNX vs KTOS Comparison

CRNX vs KTOS Comparison

Compare CRNX & KTOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • KTOS
  • Stock Information
  • Founded
  • CRNX 2008
  • KTOS 1994
  • Country
  • CRNX United States
  • KTOS United States
  • Employees
  • CRNX N/A
  • KTOS N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • KTOS Military/Government/Technical
  • Sector
  • CRNX Health Care
  • KTOS Industrials
  • Exchange
  • CRNX Nasdaq
  • KTOS Nasdaq
  • Market Cap
  • CRNX 2.8B
  • KTOS 6.2B
  • IPO Year
  • CRNX 2018
  • KTOS 1999
  • Fundamental
  • Price
  • CRNX $30.48
  • KTOS $44.72
  • Analyst Decision
  • CRNX Strong Buy
  • KTOS Buy
  • Analyst Count
  • CRNX 10
  • KTOS 11
  • Target Price
  • CRNX $75.00
  • KTOS $44.91
  • AVG Volume (30 Days)
  • CRNX 654.7K
  • KTOS 4.9M
  • Earning Date
  • CRNX 08-07-2025
  • KTOS 08-06-2025
  • Dividend Yield
  • CRNX N/A
  • KTOS N/A
  • EPS Growth
  • CRNX N/A
  • KTOS N/A
  • EPS
  • CRNX N/A
  • KTOS 0.13
  • Revenue
  • CRNX $760,000.00
  • KTOS $1,161,700,000.00
  • Revenue This Year
  • CRNX $402.12
  • KTOS $15.46
  • Revenue Next Year
  • CRNX $770.88
  • KTOS $15.70
  • P/E Ratio
  • CRNX N/A
  • KTOS $347.10
  • Revenue Growth
  • CRNX N/A
  • KTOS 7.32
  • 52 Week Low
  • CRNX $24.10
  • KTOS $17.91
  • 52 Week High
  • CRNX $62.53
  • KTOS $47.09
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 50.56
  • KTOS 59.82
  • Support Level
  • CRNX $28.98
  • KTOS $42.81
  • Resistance Level
  • CRNX $30.34
  • KTOS $46.25
  • Average True Range (ATR)
  • CRNX 1.11
  • KTOS 2.57
  • MACD
  • CRNX -0.01
  • KTOS -0.09
  • Stochastic Oscillator
  • CRNX 66.46
  • KTOS 70.70

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About KTOS Kratos Defense & Security Solutions Inc.

Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.

Share on Social Networks: